ADAR2 Is Involved in Self and Nonself Recognition of Borna Disease Virus Genomic RNA in the Nucleus

Cells use the editing activity of adenosine deaminase acting on RNA proteins (ADARs) to prevent autoimmune responses induced by self dsRNA, but viruses can exploit this process to their advantage. Borna disease virus (BoDV), a nuclear-replicating RNA virus, must escape nonself RNA sensing by the hos...

Full description

Saved in:
Bibliographic Details
Published inJournal of virology Vol. 94; no. 6
Main Authors Yanai, Mako, Kojima, Shohei, Sakai, Madoka, Komorizono, Ryo, Tomonaga, Keizo, Makino, Akiko
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 28.02.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Cells use the editing activity of adenosine deaminase acting on RNA proteins (ADARs) to prevent autoimmune responses induced by self dsRNA, but viruses can exploit this process to their advantage. Borna disease virus (BoDV), a nuclear-replicating RNA virus, must escape nonself RNA sensing by the host to establish persistent infection in the nucleus. We evaluated whether BoDV utilizes ADARs to prevent innate immune induction. ADAR2 plays a key role throughout the BoDV life cycle. ADAR2 knockdown reduced A-to-I editing of BoDV genomic RNA, leading to the induction of a strong innate immune response. These data suggest that BoDV exploits ADAR2 to edit nonself genomic RNA to appear as self RNA for innate immune evasion and establishment of persistent infection. Cells sense pathogen-derived double-stranded RNA (dsRNA) as nonself. To avoid autoimmune activation by self dsRNA, cells utilize A-to-I editing by adenosine deaminase acting on RNA 1 (ADAR1) to disrupt dsRNA structures. Considering that viruses have evolved to exploit host machinery, A-to-I editing could benefit innate immune evasion by viruses. Borna disease virus (BoDV), a nuclear-replicating RNA virus, may require escape from nonself RNA-sensing and immune responses to establish persistent infection in the nucleus; however, the strategy by which BoDV evades nonself recognition is unclear. Here, we evaluated the involvement of ADARs in BoDV infection. The infection efficiency of BoDV was markedly decreased in both ADAR1 and ADAR2 knockdown cells at the early phase of infection. Microarray analysis using ADAR2 knockdown cells revealed that ADAR2 reduces immune responses even in the absence of infection. Knockdown of ADAR2 but not ADAR1 significantly reduced the spread and titer of BoDV in infected cells. Furthermore, ADAR2 knockout decreased the infection efficiency of BoDV, and overexpression of ADAR2 rescued the reduced infectivity in ADAR2 knockdown cells. However, the growth of influenza A virus, which causes acute infection in the nucleus, was not affected by ADAR2 knockdown. Moreover, ADAR2 bound to BoDV genomic RNA and induced A-to-G mutations in the genomes of persistently infected cells. We finally demonstrated that BoDV produced in ADAR2 knockdown cells induces stronger innate immune responses than those produced in wild-type cells. Taken together, our results suggest that BoDV utilizes ADAR2 to edit its genome to appear as “self” RNA in order to maintain persistent infection in the nucleus. IMPORTANCE Cells use the editing activity of adenosine deaminase acting on RNA proteins (ADARs) to prevent autoimmune responses induced by self dsRNA, but viruses can exploit this process to their advantage. Borna disease virus (BoDV), a nuclear-replicating RNA virus, must escape nonself RNA sensing by the host to establish persistent infection in the nucleus. We evaluated whether BoDV utilizes ADARs to prevent innate immune induction. ADAR2 plays a key role throughout the BoDV life cycle. ADAR2 knockdown reduced A-to-I editing of BoDV genomic RNA, leading to the induction of a strong innate immune response. These data suggest that BoDV exploits ADAR2 to edit nonself genomic RNA to appear as self RNA for innate immune evasion and establishment of persistent infection.
AbstractList Cells use the editing activity of adenosine deaminase acting on RNA proteins (ADARs) to prevent autoimmune responses induced by self dsRNA, but viruses can exploit this process to their advantage. Borna disease virus (BoDV), a nuclear-replicating RNA virus, must escape nonself RNA sensing by the host to establish persistent infection in the nucleus. We evaluated whether BoDV utilizes ADARs to prevent innate immune induction. ADAR2 plays a key role throughout the BoDV life cycle. ADAR2 knockdown reduced A-to-I editing of BoDV genomic RNA, leading to the induction of a strong innate immune response. These data suggest that BoDV exploits ADAR2 to edit nonself genomic RNA to appear as self RNA for innate immune evasion and establishment of persistent infection. Cells sense pathogen-derived double-stranded RNA (dsRNA) as nonself. To avoid autoimmune activation by self dsRNA, cells utilize A-to-I editing by adenosine deaminase acting on RNA 1 (ADAR1) to disrupt dsRNA structures. Considering that viruses have evolved to exploit host machinery, A-to-I editing could benefit innate immune evasion by viruses. Borna disease virus (BoDV), a nuclear-replicating RNA virus, may require escape from nonself RNA-sensing and immune responses to establish persistent infection in the nucleus; however, the strategy by which BoDV evades nonself recognition is unclear. Here, we evaluated the involvement of ADARs in BoDV infection. The infection efficiency of BoDV was markedly decreased in both ADAR1 and ADAR2 knockdown cells at the early phase of infection. Microarray analysis using ADAR2 knockdown cells revealed that ADAR2 reduces immune responses even in the absence of infection. Knockdown of ADAR2 but not ADAR1 significantly reduced the spread and titer of BoDV in infected cells. Furthermore, ADAR2 knockout decreased the infection efficiency of BoDV, and overexpression of ADAR2 rescued the reduced infectivity in ADAR2 knockdown cells. However, the growth of influenza A virus, which causes acute infection in the nucleus, was not affected by ADAR2 knockdown. Moreover, ADAR2 bound to BoDV genomic RNA and induced A-to-G mutations in the genomes of persistently infected cells. We finally demonstrated that BoDV produced in ADAR2 knockdown cells induces stronger innate immune responses than those produced in wild-type cells. Taken together, our results suggest that BoDV utilizes ADAR2 to edit its genome to appear as “self” RNA in order to maintain persistent infection in the nucleus. IMPORTANCE Cells use the editing activity of adenosine deaminase acting on RNA proteins (ADARs) to prevent autoimmune responses induced by self dsRNA, but viruses can exploit this process to their advantage. Borna disease virus (BoDV), a nuclear-replicating RNA virus, must escape nonself RNA sensing by the host to establish persistent infection in the nucleus. We evaluated whether BoDV utilizes ADARs to prevent innate immune induction. ADAR2 plays a key role throughout the BoDV life cycle. ADAR2 knockdown reduced A-to-I editing of BoDV genomic RNA, leading to the induction of a strong innate immune response. These data suggest that BoDV exploits ADAR2 to edit nonself genomic RNA to appear as self RNA for innate immune evasion and establishment of persistent infection.
Cells sense pathogen-derived double-stranded RNA (dsRNA) as nonself. To avoid autoimmune activation by self dsRNA, cells utilize A-to-I editing by adenosine deaminase acting on RNA 1 (ADAR1) to disrupt dsRNA structures. Considering that viruses have evolved to exploit host machinery, A-to-I editing could benefit innate immune evasion by viruses. Borna disease virus (BoDV), a nuclear-replicating RNA virus, may require escape from nonself RNA-sensing and immune responses to establish persistent infection in the nucleus; however, the strategy by which BoDV evades nonself recognition is unclear. Here, we evaluated the involvement of ADARs in BoDV infection. The infection efficiency of BoDV was markedly decreased in both ADAR1 and ADAR2 knockdown cells at the early phase of infection. Microarray analysis using ADAR2 knockdown cells revealed that ADAR2 reduces immune responses even in the absence of infection. Knockdown of ADAR2 but not ADAR1 significantly reduced the spread and titer of BoDV in infected cells. Furthermore, ADAR2 knockout decreased the infection efficiency of BoDV, and overexpression of ADAR2 rescued the reduced infectivity in ADAR2 knockdown cells. However, the growth of influenza A virus, which causes acute infection in the nucleus, was not affected by ADAR2 knockdown. Moreover, ADAR2 bound to BoDV genomic RNA and induced A-to-G mutations in the genomes of persistently infected cells. We finally demonstrated that BoDV produced in ADAR2 knockdown cells induces stronger innate immune responses than those produced in wild-type cells. Taken together, our results suggest that BoDV utilizes ADAR2 to edit its genome to appear as "self" RNA in order to maintain persistent infection in the nucleus. Cells use the editing activity of adenosine deaminase acting on RNA proteins (ADARs) to prevent autoimmune responses induced by self dsRNA, but viruses can exploit this process to their advantage. Borna disease virus (BoDV), a nuclear-replicating RNA virus, must escape nonself RNA sensing by the host to establish persistent infection in the nucleus. We evaluated whether BoDV utilizes ADARs to prevent innate immune induction. ADAR2 plays a key role throughout the BoDV life cycle. ADAR2 knockdown reduced A-to-I editing of BoDV genomic RNA, leading to the induction of a strong innate immune response. These data suggest that BoDV exploits ADAR2 to edit nonself genomic RNA to appear as self RNA for innate immune evasion and establishment of persistent infection.
Cells sense pathogen-derived double-stranded RNA (dsRNA) as nonself. To avoid autoimmune activation by self dsRNA, cells utilize A-to-I editing by adenosine deaminase acting on RNA 1 (ADAR1) to disrupt dsRNA structures. Considering that viruses have evolved to exploit host machinery, A-to-I editing could benefit innate immune evasion by viruses. Borna disease virus (BoDV), a nuclear-replicating RNA virus, may require escape from nonself RNA-sensing and immune responses to establish persistent infection in the nucleus; however, the strategy by which BoDV evades nonself recognition is unclear. Here, we evaluated the involvement of ADARs in BoDV infection. The infection efficiency of BoDV was markedly decreased in both ADAR1 and ADAR2 knockdown cells at the early phase of infection. Microarray analysis using ADAR2 knockdown cells revealed that ADAR2 reduces immune responses even in the absence of infection. Knockdown of ADAR2 but not ADAR1 significantly reduced the spread and titer of BoDV in infected cells. Furthermore, ADAR2 knockout decreased the infection efficiency of BoDV, and overexpression of ADAR2 rescued the reduced infectivity in ADAR2 knockdown cells. However, the growth of influenza A virus, which causes acute infection in the nucleus, was not affected by ADAR2 knockdown. Moreover, ADAR2 bound to BoDV genomic RNA and induced A-to-G mutations in the genomes of persistently infected cells. We finally demonstrated that BoDV produced in ADAR2 knockdown cells induces stronger innate immune responses than those produced in wild-type cells. Taken together, our results suggest that BoDV utilizes ADAR2 to edit its genome to appear as "self" RNA in order to maintain persistent infection in the nucleus.IMPORTANCE Cells use the editing activity of adenosine deaminase acting on RNA proteins (ADARs) to prevent autoimmune responses induced by self dsRNA, but viruses can exploit this process to their advantage. Borna disease virus (BoDV), a nuclear-replicating RNA virus, must escape nonself RNA sensing by the host to establish persistent infection in the nucleus. We evaluated whether BoDV utilizes ADARs to prevent innate immune induction. ADAR2 plays a key role throughout the BoDV life cycle. ADAR2 knockdown reduced A-to-I editing of BoDV genomic RNA, leading to the induction of a strong innate immune response. These data suggest that BoDV exploits ADAR2 to edit nonself genomic RNA to appear as self RNA for innate immune evasion and establishment of persistent infection.Cells sense pathogen-derived double-stranded RNA (dsRNA) as nonself. To avoid autoimmune activation by self dsRNA, cells utilize A-to-I editing by adenosine deaminase acting on RNA 1 (ADAR1) to disrupt dsRNA structures. Considering that viruses have evolved to exploit host machinery, A-to-I editing could benefit innate immune evasion by viruses. Borna disease virus (BoDV), a nuclear-replicating RNA virus, may require escape from nonself RNA-sensing and immune responses to establish persistent infection in the nucleus; however, the strategy by which BoDV evades nonself recognition is unclear. Here, we evaluated the involvement of ADARs in BoDV infection. The infection efficiency of BoDV was markedly decreased in both ADAR1 and ADAR2 knockdown cells at the early phase of infection. Microarray analysis using ADAR2 knockdown cells revealed that ADAR2 reduces immune responses even in the absence of infection. Knockdown of ADAR2 but not ADAR1 significantly reduced the spread and titer of BoDV in infected cells. Furthermore, ADAR2 knockout decreased the infection efficiency of BoDV, and overexpression of ADAR2 rescued the reduced infectivity in ADAR2 knockdown cells. However, the growth of influenza A virus, which causes acute infection in the nucleus, was not affected by ADAR2 knockdown. Moreover, ADAR2 bound to BoDV genomic RNA and induced A-to-G mutations in the genomes of persistently infected cells. We finally demonstrated that BoDV produced in ADAR2 knockdown cells induces stronger innate immune responses than those produced in wild-type cells. Taken together, our results suggest that BoDV utilizes ADAR2 to edit its genome to appear as "self" RNA in order to maintain persistent infection in the nucleus.IMPORTANCE Cells use the editing activity of adenosine deaminase acting on RNA proteins (ADARs) to prevent autoimmune responses induced by self dsRNA, but viruses can exploit this process to their advantage. Borna disease virus (BoDV), a nuclear-replicating RNA virus, must escape nonself RNA sensing by the host to establish persistent infection in the nucleus. We evaluated whether BoDV utilizes ADARs to prevent innate immune induction. ADAR2 plays a key role throughout the BoDV life cycle. ADAR2 knockdown reduced A-to-I editing of BoDV genomic RNA, leading to the induction of a strong innate immune response. These data suggest that BoDV exploits ADAR2 to edit nonself genomic RNA to appear as self RNA for innate immune evasion and establishment of persistent infection.
Author Yanai, Mako
Makino, Akiko
Sakai, Madoka
Tomonaga, Keizo
Komorizono, Ryo
Kojima, Shohei
Author_xml – sequence: 1
  givenname: Mako
  surname: Yanai
  fullname: Yanai, Mako
  organization: Laboratory of RNA Viruses, Department of Virus Research, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan, Laboratory of RNA Viruses, Department of Mammalian Regulatory Network, Graduate School of Biostudies, Kyoto University, Kyoto, Japan
– sequence: 2
  givenname: Shohei
  surname: Kojima
  fullname: Kojima, Shohei
  organization: Laboratory of RNA Viruses, Department of Virus Research, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan
– sequence: 3
  givenname: Madoka
  surname: Sakai
  fullname: Sakai, Madoka
  organization: Laboratory of RNA Viruses, Department of Virus Research, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan, Laboratory of RNA Viruses, Department of Mammalian Regulatory Network, Graduate School of Biostudies, Kyoto University, Kyoto, Japan
– sequence: 4
  givenname: Ryo
  surname: Komorizono
  fullname: Komorizono, Ryo
  organization: Laboratory of RNA Viruses, Department of Virus Research, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan, Laboratory of RNA Viruses, Department of Mammalian Regulatory Network, Graduate School of Biostudies, Kyoto University, Kyoto, Japan
– sequence: 5
  givenname: Keizo
  surname: Tomonaga
  fullname: Tomonaga, Keizo
  organization: Laboratory of RNA Viruses, Department of Virus Research, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan, Laboratory of RNA Viruses, Department of Mammalian Regulatory Network, Graduate School of Biostudies, Kyoto University, Kyoto, Japan, Department of Molecular Virology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
– sequence: 6
  givenname: Akiko
  surname: Makino
  fullname: Makino, Akiko
  organization: Laboratory of RNA Viruses, Department of Virus Research, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan, Laboratory of RNA Viruses, Department of Mammalian Regulatory Network, Graduate School of Biostudies, Kyoto University, Kyoto, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31852792$$D View this record in MEDLINE/PubMed
BookMark eNptkUFv1DAQRi1URLeFG2fkIwdSPI4dOxekbUvLVtUiLVBxsxxn3Bpl7RInK_Hvm9BSUcTJI_nNm9F8B2QvpoiEvAZ2BMD1-4ur1REDCWUB9TOyAFbrQkoQe2TBGOeFLPX3fXKQ8w_GQIhKvCD7JWjJVc0XxC1PlxtOV5mu4i51O2xpiPQLdp7a2NJ1inmuN-jSdQxDSJEmT49THy09DRltRnoV-jHTc4xpGxzdrJezYrhBuh5dh2N-SZ5722V89fAekm9nH7-efCouP5-vTpaXhROSDYVGy5TnNQenvGwbrjS41jNtWysr0diq8gKVZb5BhgqEbVzJKlXXtkEosTwkH-69t2OzxdZhHHrbmds-bG3_yyQbzNOfGG7MddoZBVIrLibB2wdBn36OmAezDdlh19mIacyGl1yriklRT-ibv2c9Dvlz2Ql4dw-4PuXco39EgJk5ODMFZ34HZ2D28X9wFwY733vaNHT_b7oDfY6bYA
CitedBy_id crossref_primary_10_1016_j_it_2023_01_001
crossref_primary_10_1016_j_bbrc_2023_03_069
crossref_primary_10_3389_fimmu_2023_1286820
crossref_primary_10_3390_ncrna8020023
crossref_primary_10_1007_s10142_022_00910_3
crossref_primary_10_3389_fbioe_2021_792911
crossref_primary_10_3390_ijms241612612
crossref_primary_10_1146_annurev_virology_091919_065320
crossref_primary_10_1186_s13046_023_02727_9
crossref_primary_10_1093_gbe_evab240
crossref_primary_10_1016_j_tibs_2021_02_002
crossref_primary_10_1073_pnas_2112663119
crossref_primary_10_1038_s44318_024_00314_y
Cites_doi 10.1073/pnas.94.8.3542
10.1002/1873-3468.12795
10.1016/j.cell.2017.12.038
10.1126/science.1136567
10.1371/journal.pone.0108476
10.1128/mcb.15.10.5376
10.1128/jvi.76.23.12399-12404.2002
10.20506/rst.19.1.1217
10.1093/nar/gkp604
10.1126/science.1132998
10.1126/science.1170995
10.1074/jbc.270.29.17098
10.1016/0092-8674(88)90253-x
10.1371/journal.pbio.2006577
10.1186/s12985-017-0793-6
10.1111/j.1750-3639.1995.tb00598.x
10.1017/s1355838200000170
10.1128/jvi.66.2.992-998.1992
10.1038/ni1303
10.1016/j.febslet.2004.07.055
10.1128/JVI.79.10.6291-6298.2005
10.1126/science.aac7049
10.1038/19992
10.1073/pnas.91.24.11457
10.1038/nature24041
10.1038/379460a0
10.1016/j.virol.2011.10.024
10.1038/s41467-017-00354-5
10.1111/1348-0421.12505
10.1093/nar/gkh536
10.1128/JVI.02572-13
10.1093/nar/gkn923
10.1016/s0165-5728(03)00044-4
10.1016/0168-1702(85)90057-7
10.1093/emboj/17.4.1120
10.1038/323508a0
10.1128/JVI.00232-15
10.1016/0092-8674(87)90239-x
10.3390/v7052668
10.1128/JVI.02138-10
10.1073/pnas.91.10.4362
10.1073/pnas.1016759108
10.1016/0092-8674(88)90048-7
10.1016/0092-8674(93)90622-w
10.1002/j.1460-2075.1991.tb04916.x
10.1128/JVI.01017-15
10.1016/s1286-4579(02)01564-2
10.1073/pnas.86.8.2647
10.1099/0022-1317-66-11-2479
10.1038/nprot.2008.211
10.1371/journal.ppat.1005166
10.1128/JVI.01299-15
10.1073/pnas.1006183107
10.1016/0092-8674(91)90568-j
10.1073/pnas.232416799
10.1016/j.chom.2012.04.011
10.1016/j.chom.2012.04.009
10.1099/vir.0.028043-0
10.1146/annurev-genet-120116-023425
10.1038/387303a0
10.1073/pnas.1017241108
10.1128/JVI.02457-08
10.1074/jbc.M115.709014
10.1093/nar/gkw1304
10.1371/journal.ppat.1003440
10.1016/s0092-8674(01)00466-4
10.7554/eLife.25687
10.1073/pnas.89.23.11486
10.1128/JVI.02666-10
10.1074/jbc.M611392200
10.1021/bi001383g
10.1371/journal.pone.0002032
10.1016/j.virusres.2019.02.004
ContentType Journal Article
Copyright Copyright © 2020 American Society for Microbiology.
Copyright © 2020 American Society for Microbiology. 2020 American Society for Microbiology
Copyright_xml – notice: Copyright © 2020 American Society for Microbiology.
– notice: Copyright © 2020 American Society for Microbiology. 2020 American Society for Microbiology
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.1128/JVI.01513-19
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList CrossRef

PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate ADAR2 and Innate Immune Response Induced by RNA Virus
EISSN 1098-5514
ExternalDocumentID PMC7158724
31852792
10_1128_JVI_01513_19
Genre Journal Article
GroupedDBID ---
-~X
0R~
18M
29L
2WC
39C
4.4
53G
5GY
5RE
5VS
85S
AAFWJ
AAGFI
AAYXX
ABPPZ
ACGFO
ACNCT
ADBBV
AENEX
AGVNZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CITATION
CS3
DIK
E3Z
EBS
F5P
FRP
GX1
H13
HYE
HZ~
IH2
KQ8
N9A
O9-
OK1
P2P
RHI
RNS
RPM
RSF
TR2
UPT
W2D
W8F
WH7
WOQ
YQT
~02
~KM
NPM
7X8
5PM
ID FETCH-LOGICAL-c450t-8ea07f2921c7f5db2781cdf08ada564ba66f4e7a0fbe0e714abc306799abe13e3
ISSN 0022-538X
1098-5514
IngestDate Thu Aug 21 13:53:18 EDT 2025
Fri Jul 11 09:44:13 EDT 2025
Thu Apr 03 06:58:04 EDT 2025
Tue Jul 01 04:04:14 EDT 2025
Thu Apr 24 22:56:15 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords A-to-I editing
nuclear-replicating RNA virus
innate immunity
persistent infection
self/nonself
Language English
License Copyright © 2020 American Society for Microbiology.
All Rights Reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c450t-8ea07f2921c7f5db2781cdf08ada564ba66f4e7a0fbe0e714abc306799abe13e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Citation Yanai M, Kojima S, Sakai M, Komorizono R, Tomonaga K, Makino A. 2020. ADAR2 is involved in self and nonself recognition of Borna disease virus genomic RNA in the nucleus. J Virol 94:e01513-19. https://doi.org/10.1128/JVI.01513-19.
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/7158724
PMID 31852792
PQID 2328760549
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7158724
proquest_miscellaneous_2328760549
pubmed_primary_31852792
crossref_primary_10_1128_JVI_01513_19
crossref_citationtrail_10_1128_JVI_01513_19
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20200228
PublicationDateYYYYMMDD 2020-02-28
PublicationDate_xml – month: 2
  year: 2020
  text: 20200228
  day: 28
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle Journal of virology
PublicationTitleAlternate J Virol
PublicationYear 2020
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_2_26_2
e_1_3_2_49_2
e_1_3_2_28_2
Tomaselli S (e_1_3_2_43_2) 2015; 17
e_1_3_2_41_2
e_1_3_2_64_2
e_1_3_2_20_2
e_1_3_2_62_2
e_1_3_2_22_2
e_1_3_2_68_2
e_1_3_2_24_2
e_1_3_2_47_2
e_1_3_2_66_2
e_1_3_2_60_2
e_1_3_2_9_2
e_1_3_2_16_2
e_1_3_2_37_2
e_1_3_2_7_2
e_1_3_2_18_2
e_1_3_2_39_2
e_1_3_2_54_2
e_1_3_2_75_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_52_2
e_1_3_2_73_2
e_1_3_2_5_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_58_2
e_1_3_2_3_2
e_1_3_2_14_2
e_1_3_2_35_2
e_1_3_2_56_2
e_1_3_2_50_2
e_1_3_2_71_2
e_1_3_2_27_2
e_1_3_2_48_2
Ludwig H (e_1_3_2_45_2) 1988; 35
e_1_3_2_29_2
e_1_3_2_40_2
e_1_3_2_65_2
e_1_3_2_21_2
e_1_3_2_42_2
e_1_3_2_63_2
e_1_3_2_23_2
e_1_3_2_44_2
e_1_3_2_69_2
e_1_3_2_25_2
e_1_3_2_46_2
e_1_3_2_67_2
e_1_3_2_61_2
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_17_2
e_1_3_2_59_2
e_1_3_2_6_2
e_1_3_2_19_2
e_1_3_2_30_2
e_1_3_2_53_2
e_1_3_2_76_2
e_1_3_2_32_2
e_1_3_2_51_2
e_1_3_2_74_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_57_2
e_1_3_2_4_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_55_2
e_1_3_2_2_2
e_1_3_2_72_2
e_1_3_2_70_2
References_xml – ident: e_1_3_2_32_2
  doi: 10.1073/pnas.94.8.3542
– ident: e_1_3_2_19_2
  doi: 10.1002/1873-3468.12795
– ident: e_1_3_2_5_2
  doi: 10.1016/j.cell.2017.12.038
– ident: e_1_3_2_40_2
  doi: 10.1126/science.1136567
– ident: e_1_3_2_37_2
  doi: 10.1371/journal.pone.0108476
– ident: e_1_3_2_15_2
  doi: 10.1128/mcb.15.10.5376
– ident: e_1_3_2_31_2
  doi: 10.1128/jvi.76.23.12399-12404.2002
– ident: e_1_3_2_48_2
  doi: 10.20506/rst.19.1.1217
– ident: e_1_3_2_36_2
  doi: 10.1093/nar/gkp604
– ident: e_1_3_2_59_2
  doi: 10.1126/science.1132998
– ident: e_1_3_2_65_2
  doi: 10.1126/science.1170995
– ident: e_1_3_2_54_2
  doi: 10.1074/jbc.270.29.17098
– ident: e_1_3_2_10_2
  doi: 10.1016/0092-8674(88)90253-x
– ident: e_1_3_2_29_2
  doi: 10.1371/journal.pbio.2006577
– ident: e_1_3_2_69_2
  doi: 10.1186/s12985-017-0793-6
– ident: e_1_3_2_46_2
  doi: 10.1111/j.1750-3639.1995.tb00598.x
– ident: e_1_3_2_14_2
  doi: 10.1017/s1355838200000170
– ident: e_1_3_2_57_2
  doi: 10.1128/jvi.66.2.992-998.1992
– ident: e_1_3_2_2_2
  doi: 10.1038/ni1303
– ident: e_1_3_2_72_2
  doi: 10.1016/j.febslet.2004.07.055
– ident: e_1_3_2_63_2
  doi: 10.1128/JVI.79.10.6291-6298.2005
– ident: e_1_3_2_4_2
  doi: 10.1126/science.aac7049
– ident: e_1_3_2_21_2
  doi: 10.1038/19992
– ident: e_1_3_2_12_2
  doi: 10.1073/pnas.91.24.11457
– ident: e_1_3_2_17_2
  doi: 10.1038/nature24041
– ident: e_1_3_2_13_2
  doi: 10.1038/379460a0
– ident: e_1_3_2_38_2
  doi: 10.1016/j.virol.2011.10.024
– volume: 17
  start-page: 37
  year: 2015
  ident: e_1_3_2_43_2
  article-title: ADARs and the balance game between virus infection and innate immune cell response
  publication-title: Curr Issues Mol Biol
– ident: e_1_3_2_66_2
  doi: 10.1038/s41467-017-00354-5
– ident: e_1_3_2_71_2
  doi: 10.1111/1348-0421.12505
– ident: e_1_3_2_22_2
  doi: 10.1093/nar/gkh536
– ident: e_1_3_2_27_2
  doi: 10.1128/JVI.02572-13
– ident: e_1_3_2_73_2
  doi: 10.1093/nar/gkn923
– ident: e_1_3_2_56_2
  doi: 10.1016/s0165-5728(03)00044-4
– ident: e_1_3_2_68_2
  doi: 10.1016/0168-1702(85)90057-7
– ident: e_1_3_2_24_2
  doi: 10.1093/emboj/17.4.1120
– ident: e_1_3_2_30_2
  doi: 10.1038/323508a0
– ident: e_1_3_2_60_2
  doi: 10.1128/JVI.00232-15
– ident: e_1_3_2_9_2
  doi: 10.1016/0092-8674(87)90239-x
– ident: e_1_3_2_58_2
  doi: 10.3390/v7052668
– ident: e_1_3_2_62_2
  doi: 10.1128/JVI.02138-10
– ident: e_1_3_2_44_2
  doi: 10.1073/pnas.91.10.4362
– ident: e_1_3_2_50_2
  doi: 10.1073/pnas.1016759108
– ident: e_1_3_2_61_2
  doi: 10.1016/0092-8674(88)90048-7
– ident: e_1_3_2_53_2
  doi: 10.1016/0092-8674(93)90622-w
– ident: e_1_3_2_64_2
  doi: 10.1002/j.1460-2075.1991.tb04916.x
– ident: e_1_3_2_28_2
  doi: 10.1128/JVI.01017-15
– ident: e_1_3_2_47_2
  doi: 10.1016/s1286-4579(02)01564-2
– ident: e_1_3_2_11_2
  doi: 10.1073/pnas.86.8.2647
– ident: e_1_3_2_67_2
  doi: 10.1099/0022-1317-66-11-2479
– ident: e_1_3_2_74_2
  doi: 10.1038/nprot.2008.211
– ident: e_1_3_2_33_2
  doi: 10.1371/journal.ppat.1005166
– ident: e_1_3_2_52_2
  doi: 10.1128/JVI.01299-15
– ident: e_1_3_2_23_2
  doi: 10.1073/pnas.1006183107
– ident: e_1_3_2_25_2
  doi: 10.1016/0092-8674(91)90568-j
– ident: e_1_3_2_70_2
  doi: 10.1073/pnas.232416799
– ident: e_1_3_2_6_2
  doi: 10.1016/j.chom.2012.04.011
– ident: e_1_3_2_49_2
  doi: 10.1016/j.chom.2012.04.009
– ident: e_1_3_2_39_2
  doi: 10.1099/vir.0.028043-0
– ident: e_1_3_2_3_2
  doi: 10.1146/annurev-genet-120116-023425
– ident: e_1_3_2_26_2
  doi: 10.1038/387303a0
– ident: e_1_3_2_41_2
  doi: 10.1073/pnas.1017241108
– ident: e_1_3_2_35_2
  doi: 10.1128/JVI.02457-08
– ident: e_1_3_2_8_2
  doi: 10.1074/jbc.M115.709014
– ident: e_1_3_2_18_2
  doi: 10.1093/nar/gkw1304
– ident: e_1_3_2_42_2
  doi: 10.1371/journal.ppat.1003440
– ident: e_1_3_2_20_2
  doi: 10.1016/s0092-8674(01)00466-4
– ident: e_1_3_2_7_2
  doi: 10.7554/eLife.25687
– ident: e_1_3_2_75_2
  doi: 10.1073/pnas.89.23.11486
– ident: e_1_3_2_34_2
  doi: 10.1128/JVI.02666-10
– volume: 35
  start-page: 107
  year: 1988
  ident: e_1_3_2_45_2
  article-title: Borna disease: a persistent virus infection of the central nervous system
  publication-title: Prog Med Virol
– ident: e_1_3_2_55_2
  doi: 10.1074/jbc.M611392200
– ident: e_1_3_2_16_2
  doi: 10.1021/bi001383g
– ident: e_1_3_2_51_2
  doi: 10.1371/journal.pone.0002032
– ident: e_1_3_2_76_2
  doi: 10.1016/j.virusres.2019.02.004
SSID ssj0014464
Score 2.406715
Snippet Cells use the editing activity of adenosine deaminase acting on RNA proteins (ADARs) to prevent autoimmune responses induced by self dsRNA, but viruses can...
Cells sense pathogen-derived double-stranded RNA (dsRNA) as nonself. To avoid autoimmune activation by self dsRNA, cells utilize A-to-I editing by adenosine...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
SubjectTerms Virus-Cell Interactions
Title ADAR2 Is Involved in Self and Nonself Recognition of Borna Disease Virus Genomic RNA in the Nucleus
URI https://www.ncbi.nlm.nih.gov/pubmed/31852792
https://www.proquest.com/docview/2328760549
https://pubmed.ncbi.nlm.nih.gov/PMC7158724
Volume 94
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbQIiQuiDflJSPBKcqSuEmcHMtL20X0UHZX5RQ5iaOGdmPUB9Lur2fGdh7dLdLCJapcx406X8Yz45lvCHkroiIOC7DchqUfugH3cjcbssRNMrBtExnzYaGzfCfR0WlwPAtnXUBfV5dsssP8cm9dyf9IFcZArlgl-w-SbReFAfgM8oUrSBiuN5Lx6NNoypzxGtky1PK3RB4lePuXpT4SmGCi9BK5RmyOkDENP2BPYmTdxIMZ56xabddIPo3Vyc50MmoTH5Ho2EYFrhuvWB3Xj8f_ELXpa_1NLFSrxNXP6lwbp9_nai6rNpojFs3kQi1EN_1crapL0wzcmV6ofkQC3M-uwrurEABFOjN7jFGsyFuK1llf85r2xhZh0X6FzrBI4fhsfAh2iz90rX7d4c2-sp-1WYbav2FxCnen-u4U-WFvM3AotPM9_tqeN4FTHDS88vjkTYkEi9_3f3vXeLnmkVxNrO1ZKif3yT0rJToyeHlAbsn6Ibljmo5ePCK5Rg0dr2mDGlrVFFFDATXUoob2UENVSTVqqEUN1aihFjUUUINLAGqoRc1jcvrl88nHI9e22nDzIPQ2biyFx0uWMD_nZVhkjMd-XpReLAoRRkEmoqgMJBdemUlPcj8QWY7OZpKITGIg_Qk5qFUtnxEqYBAUQwG-ggywv4EXgQuia7TLPJb-gDjNf5jmloce26Es033yGpB37exfhn_lL_PeNOJIQUHiqZeopdquU3AZYMcHzwTmPDXiaVfS1AE8YQPCdwTXTkDy9d1v6mquSdi5H8acBc9v-HwvyN3uVXlJDjarrXwF5uwme62R-AdY_Z2p
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=ADAR2+Is+Involved+in+Self+and+Nonself+Recognition+of+Borna+Disease+Virus+Genomic+RNA+in+the+Nucleus&rft.jtitle=Journal+of+virology&rft.au=Yanai%2C+Mako&rft.au=Kojima%2C+Shohei&rft.au=Sakai%2C+Madoka&rft.au=Komorizono%2C+Ryo&rft.date=2020-02-28&rft.issn=0022-538X&rft.eissn=1098-5514&rft.volume=94&rft.issue=6&rft_id=info:doi/10.1128%2FJVI.01513-19&rft.externalDBID=n%2Fa&rft.externalDocID=10_1128_JVI_01513_19
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon